Insider Deck research · News

RVMD stock news · Revolution Medicines, Inc.

Latest Revolution Medicines, Inc. (RVMD) stock news, headlines, and research context on Insider Deck. Market cap $41.9B.

News desk

Revolution Medicines, Inc. wire

Read the briefing on Insider Deck — headline, teaser, and desk context stay here. Publisher sites remain optional for the full longform.

7 on the wireUpdated within the hour

MarketBeat·Thu, Aug 6, 4:03 AM

Revolution Medicines Q2 Earnings Call Highlights

Revolution Medicines (NASDAQ:RVMD) said its second-quarter 2026 results reflected continued investment in late-stage cancer programs, commercial launch preparations and manufacturing capacity as it advances daraxonrasib and other RAS-targeted therapies across pancreatic and lung cancer. The company

Insider Deck desk note

Last$197.30
Day+1.98%
SymbolRVMD

Cross-check the tape against filings and ownership — the headline is the spark; the desk is the research.

Company KPIsShareholdersBuys vs Sells
Continue on MarketBeat

Frequently asked questions

What is the latest news on RVMD?

The RVMD news desk aggregates recent headlines with research context for Revolution Medicines, Inc..

Where can I research RVMD on Insider Deck?

Revolution Medicines, Inc. (RVMD) research covers KPIs, earnings, fundamentals, institutional ownership, 13F flow, news, and DCF valuation.